Work

Correction: Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation

Year: 2026

Type: erratum

Abstract: Correction on: Zhang Q, Tang X, Liu Z, Song X, Peng D, Zhu W, Ouyang Z, Wang W. Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation. Front Pharmacol. 2018;9:1028. doi:10.3389/fphar.2018.01028.There was a mistake in Figure 1C (control and 30 μM groups) as published. During figure preparation, the images for the splenocytes control group and the 30 μM group in Figure 1C were incorrectly selected, resulting in a misrepresentation of the experimental data. The corrected Figure1 appears below.for a reason not seen here, please contact the journal's editorial office.

Source: Frontiers in Pharmacology

DOI: 10.3389/fphar.2025.1678215

Authors: Qiang Zhang, Xinqiao Tang, Zhong Liu, Xiaoxia Song, Dan Peng, Wei Zhu, Zhengxiao Ouyang, Wanchun Wang

Institutions: Central South University, Second Xiangya Hospital of Central South University, Xiangya Hospital Central South University

Language: English

Topic: Bone Metabolism and Diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801

OpenAlex ID: W7118674341

Cites:

Cited by:

Related to: